- This event has passed.
Tuesday 28th November 2017 @ 9:00 am - Wednesday 29th November 2017 @ 5:00 pm
BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations, early-stage innovation and seed investment in the field of Life Sciences. With more than 1,200 international leading actors from 35+ countries, the event gathers big pharma, emerging and small biotech companies, pre-seed/seed/Series A investors, as well as professionals from tech transfer, academia and research institutions.
The Conference Programme at a glance
New players involved in innovation in the health sector
Big data and health IT companies provide key expertise to potentially increase efficiency in the discovery, preclinical and clinical stages of development. What will be their position and involvement in the therapeutic innovation chain: Will they participate or lead? Examples of collaborations between biotech, pharma and academic research will be highlighted. However, these new players don’t only originate from the big data sector, they also come from various areas such as animal health or e-health.
Nurturing and licensing early-stage assets
Early stage assets evolve in an ecosystem in which TTOs, scientists and entrepreneurs are closely connected. This subject will focus on assessing opportunities in licensing early-stage projects, discussing the monitoring role of TTOs and exploring the scientists’ commitment. It aims to underline the difficulties for maturing early-stage assets. How can we transform science into business more frequently and efficiently?
Bioentrepreneurs’ challenges at pre-seed, seed and Series A stages
The right mindset, a solid presentation and business model are not the sole requirements that bioentrepreneurs must fulfill at pre-seed, seed and Series A stages. What are the expectations of project maturity from seed investors in 2018? How often are new types of early-stage investors involved in financing rounds (including philanthropic and specialised ventures)? How does the angles/seed investors relationship work? Are there increasing interactions and partnerships between pharma and VCs at these initial stages?
Register Now for BioFit 2017
Medilink members can receive 25% off booking fees. There are also sponsorship and exhibition opportunities available. To find out more or register your place, please click here.